''Changing Lives in New York and Surrounding Areas''       We accept all PPO Plans.
Phone #: (646) 933-0764     Email: [email protected]

Bone Marrow Derived Stem Cell Therapy

Bone Marrow Derived Stem Cell Therapy consists of specialized cells that are used to regenerate damaged or injured tissues and can help form tendon, muscle, ligament, joint, and bone cells in the affected areas of the body.

Bone Marrow Derived Stem Cell Therapy

Studies have shown that bone marrow-derived mesenchymal stem cells can trigger tendon, cartilage, ligament, bone healing and regeneration.

Administration of Bone Marrow Derived Stem Cell Therapy

Administration of the bone marrow stem cells injections does not require an overnight hospital stay and can be applied on an outpatient basis. The patients can go back to their normal daily routines after the procedure.


Physicians acquire these stem cells from the hip region and then concentrate them. Now the stem cells can easily be injected into the joint or body region.

Physicians use a real-time x-ray to make sure the cells are placed in the correct area.


Conditions for Bone Marrow Stem Cells Treatment

  • Arthritis
  • Joint injury
  • Tendinitis
  • Rotator cuff tears
  • Achilles Tendon Injury
  • Elbow Tendinosis

Instead of going for traditional ways for pain relief, every year more than 100,000 U.S. citizens opt for bone marrow stem cell therapies.

Bone marrow stem cells have the ability to differentiate into cartilage, bone, ligament, tendon, and endothelium once injected into the damaged area. By releasing various bioactive and growth factors, they help damaged tissues to regenerate.

Studies show that the bone marrow stem cells therapy has shown results in the treatment of amyotrophic lateral sclerosis, a neurodegenerative disorder, knee arthritis and treatment of focal lesions.



Hoffmann A, Gross G. Tendon and ligament engineering in the adult organism:

mesenchymal stem cells and gene-therapeutic approaches. Int Orthop. 2007


Lacitignola L, Crovace A, Rossi G, Francioso E. Cell therapy for tendinitis, experimental and clinical report. Vet Res Commun. 2008 Sep;32 Suppl 1:S33-8. doi: 10.1007/s11259-008-9085-3.

Turner CG, Klein JD, Steigman SA, Armant M, Nicksa GA, Zurakowski D, Ritz J, Fauza DO. Preclinical regulatory validation of an engineered diaphragmatic tendon made with amniotic mesenchymal stem cells. J Pediatr Surg. 2011 Jan;46(1):57-61. doi: 10.1016/j.jpedsurg.2010.09.063.;35:639–43.